GMO Benchmark-Free Allocation Fund

Scorecard
3 / 5 Stars
Lipper
5 5 5 5 2
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
---
TheStreet.com
C+ (Hold)

Fund Fees

Updated 02.13.2014

Maximum Sales Fees %
Initial
Deferred

Updated 02.13.2014

Maximum Fees %
Administrative
Management 0.65
Redemption 0.11

Updated 02.13.2014

Actual Fees %
12b-1
Management 0.65
Net Expense Ratio: Annual Report 0.54
Net Expense Ratio: Prospectus 0.9

Updated 04.22.2014

Total Cost Projections
3-Year $427.00
5-Year $763.00
10-Year $1,713.00

Purchase Information

Updated 02.13.2014

Minimum Investments
Initial $10,000,000.00
Additional
Initial IRA
Additional IRA
Initial AIP
Additional AIP